Inhibitors targeting enzymes like isocitrate dehydrogenase (IDH) (in mutant GBM), LDH (lactate dehydrogenase), and GLS (glutaminase) are being studied for their potential to starve GBM cells. The gene discussed is IDH1; the disease is glioblastoma.